Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 6Burkitt Lymphoma 4Leukemia, Biphenotypic, Acute 3Prostatic Neoplasms 2Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 1Plasmablastic Lymphoma 1Neuroblastoma 1Lymphoma 1Hodgkin Disease 1

Interventions

Cyclophosphamide 18Vincristine 13Filgrastim 13Doxorubicin 13Carboplatin 13Etoposide 12Granulocyte Colony-Stimulating Factor 10Isotretinoin 9Cisplatin 9Topotecan 8Peripheral Blood Stem Cell Transplantation 8sargramostim 7Melphalan 7Radiotherapy 6etoposide phosphate 5Thiotepa 5Polymerase Chain Reaction 5Platinum 5Magnetic Resonance Spectroscopy 4Irinotecan 4Immunohistochemistry 4Gene Expression Profiling 4Colony-Stimulating Factors 41,2-diaminocyclohexaneplatinum II citrate 4lorukafusp alfa 3dinutuximab 3Temozolomide 3Stem Cell Transplantation 3Specimen Handling 3Radiation 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Neuroblastoma × prednylidene × Clear all
NCT00033293 2023-04-18

Cyclophosphamide and Prednisone With or Without Immunoglobulin in Treating Abnormal Muscle Movement in Children With Neuroblastoma

Children's Oncology Group

Phase 3 Completed
53 enrolled 14 charts
CNS

Neuroblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡